Related Articles
Mutant p53 protein in serum could be used as a molecular marker in human breast cancer
Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers
Relationship between HER2 status and proliferation rate in breast cancer assessed by immunohistochemistry, fluorescence in situ hybridisation and standardised AgNOR analysis
Diagnostic relevance of autoantibody detection against inhibitors of apoptosis proteins in colon cancer and colon adenoma
Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.